(Q110566803)

English

COVID-19 and Toll-Like Receptor 4 (TLR4): SARS-CoV-2 May Bind and Activate TLR4 to Increase ACE2 Expression, Facilitating Entry and Causing Hyperinflammation

scientific article

In more languages

Statements

scholarly article

0 references

0 references

COVID-19 and Toll-Like Receptor 4 (TLR4): SARS-CoV-2 May Bind and Activate TLR4 to Increase ACE2 Expression, Facilitating Entry and Causing Hyperinflammation (English)

0 references

1 reference

based on heuristic

inferred from title

spike glycoprotein [SARS-CoV-2]

1 reference

based on heuristic

inferred from abstract

1 reference

based on heuristic

inferred from title

author name string

Mohamed M Aboudounya

1

0 references

Richard J Heads

2

0 references

language of work or name

0 references

publication date

2021

0 references

Mediators of Inflammation

0 references

2021

0 references

8874339

0 references

copyright license

Creative Commons Attribution 4.0 International

14 January 2021

1 reference

April 2022 Public Data File from Crossref

copyright status

1 reference

April 2022 Public Data File from Crossref

Antiviral actions of interferons

1 reference

https://api.crossref.org/works/10.1155/2021/8874339

15 January 2022

TRAM couples endocytosis of Toll-like receptor 4 to the induction of interferon-beta

1 reference

https://api.crossref.org/works/10.1155/2021/8874339

15 January 2022

Toll-like receptor signalling

1 reference

https://api.crossref.org/works/10.1155/2021/8874339

15 January 2022

Lipopolysaccharide induces lung fibroblast proliferation through Toll-like receptor 4 signaling and the phosphoinositide3-kinase-Akt pathway

1 reference

https://api.crossref.org/works/10.1155/2021/8874339

15 January 2022

Diverse functions of pulmonary collectins in host defense of the lung

1 reference

https://api.crossref.org/works/10.1155/2021/8874339

15 January 2022

Cardiac fibroblasts contribute to myocardial dysfunction in mice with sepsis: the role of NLRP3 inflammasome activation

1 reference

https://api.crossref.org/works/10.1155/2021/8874339

15 January 2022

The emerging role of Toll-like receptor 4 in myocardial inflammation

1 reference

https://api.crossref.org/works/10.1155/2021/8874339

15 January 2022

TLR2 and TLR4 mediated host immune responses in major infectious diseases: a review

1 reference

https://api.crossref.org/works/10.1155/2021/8874339

15 January 2022

The Role of TLR2, TLR4, and TLR9 in the Pathogenesis of Atherosclerosis

1 reference

https://api.crossref.org/works/10.1155/2021/8874339

15 January 2022

A critical cysteine is required for HMGB1 binding to Toll-like receptor 4 and activation of macrophage cytokine release

1 reference

https://api.crossref.org/works/10.1155/2021/8874339

15 January 2022

Toll-like receptors in cardiovascular diseases

1 reference

https://api.crossref.org/works/10.1155/2021/8874339

15 January 2022

Corticosteroids: Mechanisms of Action in Health and Disease

1 reference

https://api.crossref.org/works/10.1155/2021/8874339

15 January 2022

CD14 controls the LPS-induced endocytosis of Toll-like receptor 4

1 reference

https://api.crossref.org/works/10.1155/2021/8874339

15 January 2022

Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2.

1 reference

https://api.crossref.org/works/10.1155/2021/8874339

15 January 2022

TLR2 and TLR4 in autoimmune diseases: a comprehensive review

1 reference

https://api.crossref.org/works/10.1155/2021/8874339

15 January 2022

Viral Myocarditis and Dilated Cardiomyopathy: Etiology and Pathogenesis

1 reference

https://api.crossref.org/works/10.1155/2021/8874339

15 January 2022

MD-2 regulates LPS-induced NLRP3 inflammasome activation and IL-1beta secretion by a MyD88/NF-κB-dependent pathway in alveolar macrophages cell line

1 reference

https://api.crossref.org/works/10.1155/2021/8874339

15 January 2022

Response of human pulmonary epithelial cells to lipopolysaccharide involves Toll-like receptor 4 (TLR4)-dependent signaling pathways: evidence for an intracellular compartmentalization of TLR4.

1 reference

https://api.crossref.org/works/10.1155/2021/8874339

15 January 2022

Angiotensin-(1-7) and Vascular Function: The Clinical Context.

1 reference

https://api.crossref.org/works/10.1155/2021/8874339

15 January 2022

Mechanisms of disease: Toll-like receptors in cardiovascular disease

1 reference

https://api.crossref.org/works/10.1155/2021/8874339

15 January 2022

The TLR4 antagonist Eritoran protects mice from lethal influenza infection

1 reference

https://api.crossref.org/works/10.1155/2021/8874339

15 January 2022

Molecular and cellular mechanisms involved in cardiac remodeling after acute myocardial infarction.

1 reference

https://api.crossref.org/works/10.1155/2021/8874339

15 January 2022

The Membrane Protein of Severe Acute Respiratory Syndrome Coronavirus Functions as a Novel Cytosolic Pathogen-Associated Molecular Pattern To Promote Beta Interferon Induction via a Toll-Like-Receptor-Related TRAF3-Independent Mechanism

1 reference

https://api.crossref.org/works/10.1155/2021/8874339

15 January 2022

Innate immune receptor Toll-like receptor 4 signalling in neuropsychiatric diseases

1 reference

https://api.crossref.org/works/10.1155/2021/8874339

15 January 2022

The interplay between Angiotensin II, TLR4 and hypertension

1 reference

https://api.crossref.org/works/10.1155/2021/8874339

15 January 2022

TLR4 Signaling Pathway Modulators as Potential Therapeutics in Inflammation and Sepsis.

1 reference

https://api.crossref.org/works/10.1155/2021/8874339

15 January 2022

Increased toll-like receptor 4 in the myocardium of patients requiring left ventricular assist devices.

1 reference

https://api.crossref.org/works/10.1155/2021/8874339

15 January 2022

Toll-like receptor 4 in acute viral infection: Too much of a good thing

1 reference

https://api.crossref.org/works/10.1155/2021/8874339

15 January 2022

Identification of oxidative stress and Toll-like receptor 4 signaling as a key pathway of acute lung injury

1 reference

https://api.crossref.org/works/10.1155/2021/8874339

15 January 2022

Respiratory syncytial virus-induced activation of nuclear factor-kappaB in the lung involves alveolar macrophages and toll-like receptor 4-dependent pathways

1 reference

https://api.crossref.org/works/10.1155/2021/8874339

15 January 2022

Viral myocarditis: receptors that bridge the cardiovascular with the immune system?

1 reference

https://api.crossref.org/works/10.1155/2021/8874339

15 January 2022

Nifuroxazide, a STAT3 inhibitor, mitigates inflammatory burden and protects against diabetes-induced nephropathy in rats

1 reference

https://api.crossref.org/works/10.1155/2021/8874339

15 January 2022

IL-12 Receptor β1 and Toll-Like Receptor 4 Increase IL-1β- and IL-18-Associated Myocarditis and Coxsackievirus Replication

1 reference

https://api.crossref.org/works/10.1155/2021/8874339

15 January 2022

Phospholipid regulation of innate immunity and respiratory viral infection

1 reference

https://api.crossref.org/works/10.1155/2021/8874339

15 January 2022

Genome Composition and Divergence of the Novel Coronavirus (2019-nCoV) Originating in China

1 reference

https://api.crossref.org/works/10.1155/2021/8874339

15 January 2022

Platelet TLR4 at the crossroads of thrombosis and the innate immune response

1 reference

https://api.crossref.org/works/10.1155/2021/8874339

15 January 2022

Ablation of Toll-like receptor 9 attenuates myocardial ischemia/reperfusion injury in mice

1 reference

https://api.crossref.org/works/10.1155/2021/8874339

15 January 2022

Expressions and significances of the angiotensin-converting enzyme 2 gene, the receptor of SARS-CoV-2 for COVID-19

1 reference

https://api.crossref.org/works/10.1155/2021/8874339

15 January 2022

SARS-CoV-2 Receptor ACE2 Is an Interferon-Stimulated Gene in Human Airway Epithelial Cells and Is Detected in Specific Cell Subsets across Tissues

1 reference

https://api.crossref.org/works/10.1155/2021/8874339

15 January 2022

Potent binding of 2019 novel coronavirus spike protein by a SARS coronavirus-specific human monoclonal antibody

1 reference

https://api.crossref.org/works/10.1155/2021/8874339

15 January 2022

[Effects of angiotensin converting enzyme inhibitor/angiotensin receptor blocker on clinical characteristics of coronavirus disease 2019 patients with hypertension]

1 reference

https://api.crossref.org/works/10.1155/2021/8874339

15 January 2022

COVID-19 and the Heart

1 reference

https://api.crossref.org/works/10.1155/2021/8874339

15 January 2022

COVID-19 infection: Origin, transmission, and characteristics of human coronaviruses

1 reference

https://api.crossref.org/works/10.1155/2021/8874339

15 January 2022

COVID-19, immune system response, hyperinflammation and repurposing antirheumatic drugs

1 reference

https://api.crossref.org/works/10.1155/2021/8874339

15 January 2022

Cardiovascular Complications in Patients with COVID-19: Consequences of Viral Toxicities and Host Immune Response

1 reference

https://api.crossref.org/works/10.1155/2021/8874339

15 January 2022

Receptor Recognition by the Novel Coronavirus from Wuhan: an Analysis Based on Decade-Long Structural Studies of SARS Coronavirus

1 reference

https://api.crossref.org/works/10.1155/2021/8874339

15 January 2022

Extracellular HMGB1: a therapeutic target in severe pulmonary inflammation including COVID-19?

1 reference

https://api.crossref.org/works/10.1155/2021/8874339

15 January 2022

In silico studies on the comparative characterization of the interactions of SARS-CoV-2 spike glycoprotein with ACE-2 receptor homologs and human TLRs

1 reference

https://api.crossref.org/works/10.1155/2021/8874339

15 January 2022

Is Toll-like receptor 4 involved in the severity of COVID-19 pathology in patients with cardiometabolic comorbidities?

1 reference

https://api.crossref.org/works/10.1155/2021/8874339

15 January 2022

Longitudinal observation and decline of neutralizing antibody responses in the three months following SARS-CoV-2 infection in humans

1 reference

https://api.crossref.org/works/10.1155/2021/8874339

15 January 2022

Cell type-specific expression of the putative SARS-CoV-2 receptor ACE2 in human hearts

1 reference

https://api.crossref.org/works/10.1155/2021/8874339

15 January 2022

Reverse vaccinology approach to design a novel multi-epitope vaccine candidate against COVID-19: an in silico study

1 reference

https://api.crossref.org/works/10.1155/2021/8874339

15 January 2022

Heightened Innate Immune Responses in the Respiratory Tract of COVID-19 Patients

1 reference

https://api.crossref.org/works/10.1155/2021/8874339

15 January 2022

Alveolar lipids in pulmonary disease. A review

1 reference

https://api.crossref.org/works/10.1155/2021/8874339

15 January 2022

Type III interferons disrupt the lung epithelial barrier upon viral recognition

1 reference

https://api.crossref.org/works/10.1155/2021/8874339

15 January 2022

Dexamethasone in Hospitalized Patients with Covid-19 - Preliminary Report

1 reference

https://api.crossref.org/works/10.1155/2021/8874339

15 January 2022

Calcium signaling and mitochondrial destabilization in the triggering of the NLRP3 inflammasome

1 reference

https://api.crossref.org/works/10.1155/2021/8874339

15 January 2022

AP-1 function and regulation

1 reference

https://api.crossref.org/works/10.1155/2021/8874339

15 January 2022

MyD88 is required for protection from lethal infection with a mouse-adapted SARS-CoV.

1 reference

https://api.crossref.org/works/10.1155/2021/8874339

15 January 2022

Immunomodulatory activity of interferon-beta

1 reference

https://api.crossref.org/works/10.1155/2021/8874339

15 January 2022

Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3

1 reference

https://api.crossref.org/works/10.1155/2021/8874339

15 January 2022

Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA

1 reference

https://api.crossref.org/works/10.1155/2021/8874339

15 January 2022

Diagnosis and treatment of viral myocarditis

1 reference

https://api.crossref.org/works/10.1155/2021/8874339

15 January 2022

Pulmonary surfactant: an immunological perspective

1 reference

https://api.crossref.org/works/10.1155/2021/8874339

15 January 2022

Heart in sepsis : Molecular mechanisms, diagnosis and therapy of septic cardiomyopathy

1 reference

https://api.crossref.org/works/10.1155/2021/8874339

15 January 2022

Interferon regulatory factor 3 plays an anti-inflammatory role in microglia by activating the PI3K/Akt pathway

1 reference

https://api.crossref.org/works/10.1155/2021/8874339

15 January 2022

ACE2: from vasopeptidase to SARS virus receptor

1 reference

https://api.crossref.org/works/10.1155/2021/8874339

15 January 2022

Respiratory epithelial cells require Toll-like receptor 4 for induction of human beta-defensin 2 by lipopolysaccharide

1 reference

https://api.crossref.org/works/10.1155/2021/8874339

15 January 2022

Differential response of primary alveolar type I and type II cells to LPS stimulation

1 reference

https://api.crossref.org/works/10.1155/2021/8874339

15 January 2022

A randomized, double-blind, placebo-controlled trial of TAK-242 for the treatment of severe sepsis

1 reference

https://api.crossref.org/works/10.1155/2021/8874339

15 January 2022

Critical role of extracellular heat shock cognate protein 70 in the myocardial inflammatory response and cardiac dysfunction after global ischemia-reperfusion.

1 reference

https://api.crossref.org/works/10.1155/2021/8874339

15 January 2022

TAK-242 (resatorvid), a small-molecule inhibitor of Toll-like receptor (TLR) 4 signaling, binds selectively to TLR4 and interferes with interactions between TLR4 and its adaptor molecules.

1 reference

https://api.crossref.org/works/10.1155/2021/8874339

15 January 2022

Toll-Like Receptor 3 Signaling via TRIF Contributes to a Protective Innate Immune Response to Severe Acute Respiratory Syndrome Coronavirus Infection

1 reference

https://api.crossref.org/works/10.1155/2021/8874339

15 January 2022

Reading the viral signature by Toll-like receptors and other pattern recognition receptors

1 reference

https://api.crossref.org/works/10.1155/2021/8874339

15 January 2022

A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury

1 reference

https://api.crossref.org/works/10.1155/2021/8874339

15 January 2022

Make yourself at home: viral hijacking of the PI3K/Akt signaling pathway

1 reference

https://api.crossref.org/works/10.1155/2021/8874339

15 January 2022

Toll-Like Receptor-4 Signaling Drives Persistent Fibroblast Activation and Prevents Fibrosis Resolution in Scleroderma

1 reference

https://api.crossref.org/works/10.1155/2021/8874339

15 January 2022

Surfactant lipids regulate LPS-induced interleukin-8 production in A549 lung epithelial cells by inhibiting translocation of TLR4 into lipid raft domains

1 reference

https://api.crossref.org/works/10.1155/2021/8874339

15 January 2022

Cardioprotective role for angiotensin-(1-7) and angiotensin converting enzyme 2 in the heart

1 reference

https://api.crossref.org/works/10.1155/2021/8874339

15 January 2022

Toll-like receptor 4 contributes to a myofibroblast phenotype in cardiac fibroblasts and is associated with autophagy after myocardial infarction in a mouse model

1 reference

https://api.crossref.org/works/10.1155/2021/8874339

15 January 2022

Toll4 (TLR4) expression in cardiac myocytes in normal and failing myocardium

1 reference

https://api.crossref.org/works/10.1155/2021/8874339

15 January 2022

Toll-Like Receptor 4 Mediates Maladaptive Left Ventricular Remodeling and Impairs Cardiac Function After Myocardial Infarction

1 reference

https://api.crossref.org/works/10.1155/2021/8874339

15 January 2022

Bacterial lipopolysaccharide promotes profibrotic activation of intestinal fibroblasts.

1 reference

https://api.crossref.org/works/10.1155/2021/8874339

15 January 2022

Transcriptional profiling of interferon regulatory factor 3 target genes: direct involvement in the regulation of interferon-stimulated genes

1 reference

https://api.crossref.org/works/10.1155/2021/8874339

15 January 2022

Effect of Toll-like receptor 4 inhibitor on LPS-induced lung injury.

1 reference

https://api.crossref.org/works/10.1155/2021/8874339

15 January 2022

The coxsackie-adenovirus receptor (CAR) is used by reference strains and clinical isolates representing all six serotypes of coxsackievirus group B and by swine vesicular disease virus.

1 reference

https://api.crossref.org/works/10.1155/2021/8874339

15 January 2022

Protein kinase Cε-calcineurin cosignaling downstream of toll-like receptor 4 downregulates fibrosis and induces wound healing gene expression in cardiac myofibroblasts.

1 reference

https://api.crossref.org/works/10.1155/2021/8874339

15 January 2022

Reduced cardiac hypertrophy in toll-like receptor 4-deficient mice following pressure overload

1 reference

https://api.crossref.org/works/10.1155/2021/8874339

15 January 2022

Integration of Canonical and Noncanonical Pathways in TLR4 Signaling: Complex Regulation of the Wound Repair Program

1 reference

https://api.crossref.org/works/10.1155/2021/8874339

15 January 2022

Inhibition of Toll-like receptor 4 with eritoran attenuates myocardial ischemia-reperfusion injury

1 reference

https://api.crossref.org/works/10.1155/2021/8874339

15 January 2022

Cellular and molecular mechanisms underlying LPS-associated myocyte impairment

1 reference

https://api.crossref.org/works/10.1155/2021/8874339

15 January 2022

The ACE2 expression in human heart indicates new potential mechanism of heart injury among patients infected with SARS-CoV-2

1 reference

https://api.crossref.org/works/10.1155/2021/8874339

15 January 2022

COVID-19 and lung pathology

1 reference

https://api.crossref.org/works/10.1155/2021/8874339

15 January 2022

Complex Immune Dysregulation in COVID-19 Patients with Severe Respiratory Failure

1 reference

https://api.crossref.org/works/10.1155/2021/8874339

15 January 2022

Impaired type I interferon activity and inflammatory responses in severe COVID-19 patients

1 reference

https://api.crossref.org/works/10.1155/2021/8874339

15 January 2022

Effects of the TLR4/Myd88/NF-κB Signaling Pathway on NLRP3 Inflammasome in Coronary Microembolization-Induced Myocardial Injury

1 reference

https://api.crossref.org/works/10.1155/2021/8874339

15 January 2022

Epitope-based chimeric peptide vaccine design against S, M and E proteins of SARS-CoV-2, the etiologic agent of COVID-19 pandemic: an in silico approach

1 reference

https://api.crossref.org/works/10.1155/2021/8874339

15 January 2022

Changes of Laboratory Cardiac Markers and Mechanisms of Cardiac Injury in Coronavirus Disease 2019

1 reference

https://api.crossref.org/works/10.1155/2021/8874339

15 January 2022

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

1 reference

https://api.crossref.org/works/10.1155/2021/8874339

15 January 2022

Single-cell RNA-seq data analysis on the receptor ACE2 expression reveals the potential risk of different human organs vulnerable to 2019-nCoV infection

1 reference

https://api.crossref.org/works/10.1155/2021/8874339

15 January 2022

Increased cardiomyocyte intracellular calcium during endotoxin-induced cardiac dysfunction in guinea pigs

1 reference

https://api.crossref.org/works/10.1155/2021/8874339

15 January 2022

The toll-like receptor 4-antagonist eritoran reduces murine cardiac hypertrophy

1 reference

https://api.crossref.org/works/10.1155/2021/8874339

15 January 2022

COVID-19 and the cardiovascular system

1 reference

https://api.crossref.org/works/10.1155/2021/8874339

15 January 2022

ACE2 exhibits protective effects against LPS-induced acute lung injury in mice by inhibiting the LPS-TLR4 pathway

1 reference

https://api.crossref.org/works/10.1155/2021/8874339

15 January 2022

[Miocarditis in Patients with COVID-19 Confirmed by Immunohistochemical]

1 reference

https://api.crossref.org/works/10.1155/2021/8874339

15 January 2022

Surfactant replacement therapy for preterm and term neonates with respiratory distress.

1 reference

https://api.crossref.org/works/10.1155/2021/8874339

15 January 2022

Myeloid differentiation factor-88 plays a crucial role in the pathogenesis of Coxsackievirus B3-induced myocarditis and influences type I interferon production.

1 reference

https://api.crossref.org/works/10.1155/2021/8874339

15 January 2022

TRIF is a critical survival factor in viral cardiomyopathy

1 reference

https://api.crossref.org/works/10.1155/2021/8874339

15 January 2022

Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China

1 reference

https://api.crossref.org/works/10.1155/2021/8874339

15 January 2022

Clinical Characteristics of Coronavirus Disease 2019 in China

1 reference

https://api.crossref.org/works/10.1155/2021/8874339

15 January 2022

Activation of NLRP3 inflammasome by lymphocytic microparticles via TLR4 pathway contributes to airway inflammation

1 reference

https://api.crossref.org/works/10.1155/2021/8874339

15 January 2022

Toll-like receptor-induced cytokines as immunotherapeutic targets in cancers and autoimmune diseases

1 reference

https://api.crossref.org/works/10.1155/2021/8874339

15 January 2022

A pneumonia outbreak associated with a new coronavirus of probable bat origin

1 reference

https://api.crossref.org/works/10.1155/2021/8874339

15 January 2022

Preliminary Identification of Potential Vaccine Targets for the COVID-19 Coronavirus (SARS-CoV-2) Based on SARS-CoV Immunological Studies

1 reference

https://api.crossref.org/works/10.1155/2021/8874339

15 January 2022

Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China

1 reference

https://api.crossref.org/works/10.1155/2021/8874339

15 January 2022

A novel role of nifuroxazide in attenuation of sepsis-associated acute lung and myocardial injuries; role of TLR4/NLPR3/IL-1β signaling interruption

1 reference

https://api.crossref.org/works/10.1155/2021/8874339

15 January 2022

Designing a multi-epitope vaccine against SARS-CoV-2: an immunoinformatics approach

1 reference

https://api.crossref.org/works/10.1155/2021/8874339

15 January 2022

Outcomes of Cardiovascular Magnetic Resonance Imaging in Patients Recently Recovered From Coronavirus Disease 2019 (COVID-19)

1 reference

https://api.crossref.org/works/10.1155/2021/8874339

15 January 2022

Vaccine Design from the Ensemble of Surface Glycoprotein Epitopes of SARS-CoV-2: An Immunoinformatics Approach

1 reference

https://api.crossref.org/works/10.1155/2021/8874339

15 January 2022

Targeting human TLRs to combat COVID-19: A solution?

1 reference

https://api.crossref.org/works/10.1155/2021/8874339

15 January 2022

COVID-19 Patients Upregulate Toll-like Receptor 4-mediated Inflammatory Signaling That Mimics Bacterial Sepsis

1 reference

https://api.crossref.org/works/10.1155/2021/8874339

15 January 2022

EXPLORING SURFACE GLYCOPROTEIN TO DESIGN MULTI-EPITOPE VACCINE AGAINST COVID-19

1 reference

https://api.crossref.org/works/10.1155/2021/8874339

15 January 2022

Symptomatic Protective Action of Glycyrrhizin (Licorice) in COVID-19 Infection?

1 reference

https://api.crossref.org/works/10.1155/2021/8874339

15 January 2022

A candidate multi-epitope vaccine against SARS-CoV-2

1 reference

https://api.crossref.org/works/10.1155/2021/8874339

15 January 2022

Clinical characteristics of 82 cases of death from COVID-19

1 reference

https://api.crossref.org/works/10.1155/2021/8874339

15 January 2022

Longitudinal analyses reveal immunological misfiring in severe COVID-19

1 reference

https://api.crossref.org/works/10.1155/2021/8874339

15 January 2022

Identification of the Receptor Binding Domain of the Mouse Mammary Tumor Virus Envelope Protein

1 reference

https://api.crossref.org/works/10.1155/2021/8874339

15 January 2022

Modulating Toll-like receptor mediated signaling by (1-->3)-beta-D-glucan rapidly induces cardioprotection

1 reference

https://api.crossref.org/works/10.1155/2021/8874339

15 January 2022

Mechanisms of type I interferon action and its role in infections and diseases transmission in mammals

1 reference

https://api.crossref.org/works/10.1155/2021/8874339

15 January 2022

HMGB1 Neutralizing Antibody Attenuates Cardiac Injury and Apoptosis Induced by Hemorrhagic Shock/Resuscitation in Rats

1 reference

https://api.crossref.org/works/10.1155/2021/8874339

15 January 2022

Ebola virus glycoprotein directly triggers T lymphocyte death despite of the lack of infection

1 reference

https://api.crossref.org/works/10.1155/2021/8874339

15 January 2022

Detection of severe acute respiratory syndrome-associated coronavirus in pneumocytes of the lung

1 reference

https://api.crossref.org/works/10.1155/2021/8874339

15 January 2022

The Role of Toll-Like Receptor 4 in Infectious and Noninfectious Inflammation

1 reference

https://api.crossref.org/works/10.1155/2021/8874339

15 January 2022

Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus

1 reference

https://api.crossref.org/works/10.1155/2021/8874339

15 January 2022

Pathogen recognition and innate immunity

1 reference

https://api.crossref.org/works/10.1155/2021/8874339

15 January 2022

Toll-like receptor 4-dependent activation of dendritic cells by a retrovirus.

1 reference

https://api.crossref.org/works/10.1155/2021/8874339

15 January 2022

TLR4-Upregulated IL-1β and IL-1RI Promote Alveolar Macrophage Pyroptosis and Lung Inflammation through an Autocrine Mechanism.

1 reference

https://api.crossref.org/works/10.1155/2021/8874339

15 January 2022

Anionic pulmonary surfactant phospholipids inhibit inflammatory responses from alveolar macrophages and U937 cells by binding the lipopolysaccharide-interacting proteins CD14 and MD-2.

1 reference

https://api.crossref.org/works/10.1155/2021/8874339

15 January 2022

Psoriasis and extra domain A fibronectin loops

1 reference

https://api.crossref.org/works/10.1155/2021/8874339

15 January 2022

Hemin inhibits NLRP3 inflammasome activation in sepsis-induced acute lung injury, involving heme oxygenase-1.

1 reference

https://api.crossref.org/works/10.1155/2021/8874339

15 January 2022

Early innate immune responses to bacterial LPS.

1 reference

https://api.crossref.org/works/10.1155/2021/8874339

15 January 2022

Evolution of surfactant therapy for respiratory distress syndrome: past, present, and future

1 reference

https://api.crossref.org/works/10.1155/2021/8874339

15 January 2022

Suppression of TLR-4-related inflammatory pathway and anti-fibrosis effects of probiotic-fermented purple sweet potato yogurt in hearts of spontaneously hypertensive rats.

1 reference

https://api.crossref.org/works/10.1155/2021/8874339

15 January 2022

Expression of functional toll-like receptor-2 and -4 on alveolar epithelial cells.

1 reference

https://api.crossref.org/works/10.1155/2021/8874339

15 January 2022

Toll-like receptor 4 promotes fibrosis in bleomycin-induced lung injury in mice.

1 reference

https://api.crossref.org/works/10.1155/2021/8874339

15 January 2022

Interferon-stimulated genes and their antiviral effector functions

1 reference

https://api.crossref.org/works/10.1155/2021/8874339

15 January 2022

Interferon-mediated immunopathological events are associated with atypical innate and adaptive immune responses in patients with severe acute respiratory syndrome

1 reference

https://api.crossref.org/works/10.1155/2021/8874339

15 January 2022

Tissue-specific mRNA expression profiles of human toll-like receptors and related genes

1 reference

https://api.crossref.org/works/10.1155/2021/8874339

15 January 2022

Novel strategies for targeting innate immune responses to influenza.

1 reference

https://api.crossref.org/works/10.1155/2021/8874339

15 January 2022

Local renin-angiotensin II systems, angiotensin-converting enzyme and its homologue ACE2: their potential role in the pathogenesis of chronic obstructive pulmonary diseases, pulmonary hypertension and acute respiratory distress syndrome

1 reference

https://api.crossref.org/works/10.1155/2021/8874339

15 January 2022

Pathogenesis of influenza-induced acute respiratory distress syndrome.

1 reference

https://api.crossref.org/works/10.1155/2021/8874339

15 January 2022

Inflammatory and fibrotic responses of cardiac fibroblasts to myocardial damage associated molecular patterns (DAMPs).

1 reference

https://api.crossref.org/works/10.1155/2021/8874339

15 January 2022

Respiratory syncytial virus up-regulates TLR4 and sensitizes airway epithelial cells to endotoxin.

1 reference

https://api.crossref.org/works/10.1155/2021/8874339

15 January 2022

Therapeutic effects of STAT3 inhibition by nifuroxazide on murine acute graft graft-vs.-host disease: Old drug, new use.

1 reference

https://api.crossref.org/works/10.1155/2021/8874339

15 January 2022

Toll-like receptor-4 mediates lipopolysaccharide-induced signal transduction

1 reference

https://api.crossref.org/works/10.1155/2021/8874339

15 January 2022

Pulmonary surfactant and bacterial lipopolysaccharide: the interaction and its functional consequences.

1 reference

https://api.crossref.org/works/10.1155/2021/8874339

15 January 2022

TLR4-dependent fibroblast activation drives persistent organ fibrosis in skin and lung

1 reference

https://api.crossref.org/works/10.1155/2021/8874339

15 January 2022

Toll-Like Receptor Signaling and Its Inducible Proteins

1 reference

https://api.crossref.org/works/10.1155/2021/8874339

15 January 2022

Identifiers

10.1155/2021/8874339

0 references

0 references

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q110566803&oldid=1997852583"